Insiders · Profile

Tanguler Tolga

EVP, Chief Commercial Officer at ALNYLAM PHARMACEUTICALS. Filing since 5 Jul 2022. CIK 0001849458

Company
Date
Role
Action
Shares
Amount
Of holding
4 Mar 2026
EVP, Chief Commercial Officer
Sold at will
2,309
$745.98K
6.3%
2 Mar 2026
EVP, Chief Commercial Officer
Sold at will
1,598
$523.58K
4.2%
13 Feb 2026
EVP, Chief Commercial Officer
Sold at will
1,959
$607.45K
5.8%
12 Jan 2026
EVP, Chief Commercial Officer
Sold at will
1,510
$547.93K
4.8%
2 Oct 2025
EVP, Chief Commercial Officer
Sold at will
1,405
$635.13K
4.9%
29 Aug 2025
EVP, Chief Commercial Officer
Sold on a plan
3,474
$1.56M
11.8%
18 Aug 2025
EVP, Chief Commercial Officer
Sold at will
1,396
$632.76K
4.5%
3 Mar 2025
EVP, Chief Commercial Officer
Sold at will
471
$114.82K
1.7%
28 Feb 2025
EVP, Chief Commercial Officer
Sold at will
513
$123.98K
3.5%
26 Nov 2024
EVP, Chief Commercial Officer
Sold at will
1,469
$368.69K
10.0%
25 Jun 2024
EVP, Chief Commercial Officer
Sold at will
1,605
$370.75K
12.1%
28 Feb 2024
EVP, Chief Commercial Officer
Sold at will
501
$77.81K
8.7%
16 Feb 2024
EVP, Chief Commercial Officer
Sold at will
1,009
$149.40K
19.9%
27 Apr 2023
EVP, Chief Commercial Officer
Sold at will
1,476
$287.21K
45.0%
3 Feb 2023
EVP, Chief Commercial Officer
Sold, plan not stated
3,424
$794.85K
100%
2 Feb 2023
EVP, Chief Commercial Officer
Sold, plan not stated
1,601
$361.84K
31.9%
5 Aug 2022
EVP, Chief Commercial Officer
Sold, plan not stated
1,841
$401.63K
100%
3 Aug 2022
EVP, Chief Commercial Officer
Sold, plan not stated
1,754
$368.34K
32.6%
5 Jul 2022
EVP, Chief Commercial Officer
Sold, plan not stated
1,754
$263.10K
50.0%
19 decisions on file.